Effectiveness of Paricalcitol in Reducing Parathyroid Hormone Levels in X-linked Hypophosphatemic Rickets

Diseases and Conditions Researched

Hyperparathyroidism; Hypophosphatemia, Familial

What is the purpose of this trial?

The purpose of this study is to determine the effectiveness of paricalcitol, a form of synthetic vitamin D, in lowering parathyroid hormone (PTH) levels and reducing disease symptoms in children and adults with X-linked hypophosphatemic (XLH) rickets.


Participation Guidelines

Age: 9 Years and older
Gender: Both

Click here for detailed participation information for this trial.

Sponsors: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); National Institutes of Health; Yale University
Dates:
Last Updated:
Study HIC#: 0607001636